ReviewDiabetes, obesity & metabolism2026

Beyond diabetes and obesity: GLP-1 receptor agonists in disrupting the vicious cycle of metabolic dysfunction and neuroinflammation.

Renata Spezani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.